Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system

被引:61
作者
Crawford, Lindsey [1 ]
Rosch, Justin [1 ]
Putnam, David [1 ,2 ]
机构
[1] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
[2] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA
基金
美国国家科学基金会;
关键词
Blood brain barrier; CNS delivery; CONVECTION-ENHANCED DELIVERY; SOLID LIPID NANOPARTICLES; RABIES VIRUS GLYCOPROTEIN; PEGYLATED LIPOSOMAL DOXORUBICIN; FOCUSED-ULTRASOUND DISRUPTION; DUAL-FUNCTIONAL NANOPARTICLES; CONJUGATED PLGA NANOPARTICLES; ISCHEMIA-REPERFUSION INJURY; IRON-OXIDE NANOPARTICLES; IN-VIVO;
D O I
10.1016/j.jconrel.2015.12.041
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
While neurodegenerative diseases and cancers are on the rise, treatments for diseases of the central nervous system (CNS) remain limited. The blood brain barrier (BBB) poses the greatest challenge to CNS drug delivery and has therefore been a primary focus in the development of novel CNS drug delivery techniques. Limitations set by the BBB include molecule size, polarity, substrate specificity, and active efflux mechanisms. Strategies to overcome these challenges include drug delivery systems in conjunction with other chemical and physical targeting or BBB disruption mechanisms. This review outlines and describes the recent strategies employed to overcome challenges of drug delivery to the CNS while providing insight into promising techniques for future work. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:251 / 266
页数:16
相关论文
共 255 条
[11]  
[Anonymous], MOL PHARM
[12]  
[Anonymous], 2015, CANC FACTS FIG 2015
[13]   Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: A safety studyle [J].
Aryal, Muna ;
Vykhodtseva, Natalia ;
Zhang, Yong-Zhi ;
McDannold, Nathan .
JOURNAL OF CONTROLLED RELEASE, 2015, 204 :60-69
[14]   Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system [J].
Aryal, Muna ;
Arvanitis, Costas D. ;
Alexander, Phillip M. ;
McDannold, Nathan .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 72 :94-109
[15]   Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo [J].
Astary, Garrett W. ;
Kantorovich, Svetlana ;
Carney, Paul R. ;
Mareci, Thomas H. ;
Sarntinoranont, Malisa .
JOURNAL OF NEUROSCIENCE METHODS, 2010, 187 (01) :129-137
[16]   ULTRASONICALLY PRODUCED CHANGES IN THE BLOOD-BRAIN BARRIER [J].
BAKAY, L ;
HUETER, TF ;
BALLANTINE, HT ;
SOSA, D .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1956, 76 (NOV) :457-467
[17]   Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port [J].
Barua, N. U. ;
Woolley, M. ;
Bienemann, A. S. ;
Johnson, D. E. ;
Lewis, O. ;
Wyatt, M. J. ;
Irving, C. ;
O'Sullivan, S. ;
Murray, G. ;
Fennelly, C. ;
Skinner, P. ;
Gill, S. S. .
JOURNAL OF NEUROSCIENCE METHODS, 2013, 214 (02) :223-232
[18]   Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles [J].
Baseri, Babak ;
Choi, James J. ;
Deffieux, Thomas ;
Samiotaki, Gesthimani ;
Tung, Yao-Sheng ;
Olumolade, Oluyemi ;
Small, Scott A. ;
Morrison, Barclay, III ;
Konofagou, Elisa E. .
PHYSICS IN MEDICINE AND BIOLOGY, 2012, 57 (07) :N65-N81
[19]   Convection enhanced drug delivery of BDNF through a microcannula in a rodent model to strengthen connectivity of a peripheral motor nerve bridge model to bypass spinal cord injury [J].
Bauknight, W. Martin ;
Chakrabarty, Samit ;
Hwang, Brian Y. ;
Malone, Hani R. ;
Joshi, Shailendra ;
Bruce, Jeffrey N. ;
Connolly, E. Sander ;
Winfree, Christopher J. ;
Cunningham, Miles G. ;
Martin, John H. ;
Haque, Raqeeb .
JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (04) :563-569
[20]   Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review [J].
Bicker, Joana ;
Alves, Gilberto ;
Fortuna, Ana ;
Falcao, Amilcar .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (03) :409-432